Long-term clinical outcomes after deferral of percutaneous coronary intervention of intermediate coronary stenoses based on coronary pressure-derived fractional flow reserve

Journal of Cardiology

Volumn 58, Issue 1, 2011, Pages 32-37

  Misaka, Tomofumi ^a   Kunii, Hiroyuki ^a   Mizukami, Hiroyuki ^a   Sakamoto, Nobuo ^a   Nakazato, Kazuhiko ^a   Takeishi, Yasuchika ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Fractional flow reserve; Long term outcome; MACE.; Percutaneous coronary intervention

Indexed keywords

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY PRESSURE; DISEASE SEVERITY; FEMALE; FOLLOW UP; FRACTIONAL FLOW RESERVE; HEART DEATH; HUMAN; MAJOR ADVERSE CARDIAC EVENT; MALE; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; RISK ASSESSMENT; THERAPY DELAY; TREATMENT INDICATION; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CORONARY STENOSIS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; FRACTIONAL FLOW RESERVE, MYOCARDIAL; HUMANS; MALE;

EID: 80955179491     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2011.03.007     Document Type: Article

References (22)

1. Pijls N.H., Van Gelder B., Van der Voort P., Peels K., Bracke F.A., Bonnier H.J., el Gamal M.I. Fractional flow reserve. A useful index to evaluate the influence of an epicardial coronary stenosis on myocardial blood flow. Circulation 1995, 92:3183-3193.
2. Pijls N.H., De Bruyne B., Peels K., Van Der Voort P.H., Bonnier H.J., Bartunek J., Koolen J.J. Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. N Engl J Med 1996, 334:1703-1708.
3. Smith S.C., Feldman T.E., Hirshfeld J.W., Jacobs A.K., Kern M.J., King S.B., Morrison D.A., O'Neil W.W., Schaff H.V., Whitlow P.L., Williams D.O., Antman E.M., Adams C.D., Anderson J.L., Faxon D.P., et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention). Circulation 2006, 113:e166-286.
4. Tonino P.A., De Bruyne B., Pijls N.H., Siebert U., Ikeno F., van't Veer M., Klauss V., Manoharan G., Engstrøm T., Oldroyd K.G., Ver Lee P.N., MacCarthy P.A., Fearon W.F. FAME Study Investigators. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med 2009, 360:213-224.
5. Davies R.F., Goldberg A.D., Forman S., Pepine C.J., Knatterud G.L., Geller N., Sopko G., Pratt C., Deanfield J., Conti C.R. Asymptomatic Cardiac Ischemia Pilot (ACIP) study two-year follow-up: outcomes of patients randomized to initial strategies of medical therapy versus revascularization. Circulation 1997, 95:2037-2043.
6. Moses J.W., Stone G.W., Nikolsky E., Mintz G.S., Dangas G., Grube E., Ellis S.G., Lansky A.J., Weisz G., Fahy M., Na Y., Russell M.E., Donohoe D., Leon M.B., Mehran R. Drug-eluting stents in the treatment of intermediate lesions: pooled analysis from four randomized trials. J Am Coll Cardiol 2006, 47:2164-2171.
7. Boden W.E., O'Rourke R.A., Teo K.K., Hartigan P.M., Maron D.J., Kostuk W.J., Knudtson M., Dada M., Casperson P., Harris C.L., Chaitman B.R., Shaw L., Gosselin G., Nawaz S., Title L.M., et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007, 356:1503-1516.
8. Pijls N.H., van Schaardenburgh P., Manoharan G., Boersma E., Bech J.W., van't Veer M., Bär F., Hoorntje J., Koolen J., Wijns W., de Bruyne B. Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER Study. J Am Coll Cardiol 2007, 49:2105-2111.
9. Bech G.J., De Bruyne B., Bonnier H.J., Bartunek J., Wijns W., Peels K., Heyndrickx G.R., Koolen J.J., Pijls N.H. Long-term follow-up after deferral of percutaneous transluminal coronary angioplasty of intermediate stenosis on the basis of coronary pressure measurement. J Am Coll Cardiol 1998, 31:841-847.
10. Tanaka H., Chikamori T., Tanaka N., Hida S., Shindo N., Igarashi Y., Yamashina A. A flow-limiting stenosis is the major determinant of exercise-induced myocardial stunning in patients with coronary artery disease. J Cardiol 2010, 55:337-344.
11. Hachamovitch R., Berman D.S., Shaw L.J., Kiat H., Cohen I., Cabico J.A., Friedman J., Diamond G.A. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction. Circulation 1998, 97:535-543.
12. Berger A., Botman K.J., MacCarthy P.A., Wijns W., Bartunek J., Heyndrickx G.R., Pijls N.H., De Bruyne B. Long-term clinical outcome after fractional flow reserve-guided percutaneous coronary intervention in patients with multivessel disease. J Am Coll Cardiol 2005, 46:438-442.
13. Hamilos M., Muller O., Cuisset T., Ntalianis A., Chlouverakis G., Sarno G., Nelis O., Bartunek J., Vanderheyden M., Wyffels E., Barbato E., Heyndrickx G.R., Wijns W., De Bruyne B. Long-term clinical outcome after fractional flow reserve-guided treatment in patients with angiographically equivocal left main coronary artery stenosis. Circulation 2009, 120:1505-1512.
14. Kobori Y., Tanaka N., Takazawa K., Yamashina A. Usefulness of fractional flow reserve in determining the indication of target lesion revascularization. Catheter Cardiovasc Interv 2005, 65:355-360.
15. Kern M.J., Lerman A., Bech J.W., De Bruyne B., Eeckhout E., Fearon W.F., Higano S.T., Lim M.J., Meuwissen M., Piek J.J., Pijls N.H., Siebes M., Spaan J.A. American Heart Association Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology. Physiological assessment of coronary artery disease in the cardiac catheterization laboratory: a scientific statement from the American Heart Association Committee on Diagnostic and Interventional Cardiac Catheterization. Council on Clinical Cardiology. Circulation 2006, 114:1321-1341.
16. Legalery P., Schiele F., Seronde M.F., Meneveau N., Wei H., Didier K., Blonde M.C., Caulfield F., Bassand J.P. One-year outcome of patients submitted to routine fractional flow reserve assessment to determine the need for angioplasty. Eur Heart J 2005, 26:2623-2629.
17. Courtis J., Rodes-Cabau J., Larose E., Dery J.P., Nguyen C.M., Proulx G., Gleeton O., Roy L., Barbeau G., Noël B., DeLarochellière R., Bertrand O.F. Comparison of medical treatment and coronary revascularization in patients with moderate coronary lesions and borderline fractional flow reserve measurements. Catheter Cardiovasc Interv 2008, 71:541-548.
18. Falk E., Shah P.K., Fuster V. Coronary plaque disruption. Circulation 1995, 92:657-671.
19. Schaar J.A., Muller J.E., Falk E., Virmani R., Fuster V., Serruys P.W., Colombo A., Stefanadis C., Ward Casscells S., Moreno P.R., Maseri A., van der Steen A.F. Terminology for high-risk and vulnerable coronary artery plaques. Report of a meeting on the vulnerable plaque, June 17 and 18, 2003, Santorini, Greece. Eur Heart J 2004, 25:1077-1082.
20. Matter C.M., Stuber M., Nahrendorf M. Imaging of the unstable plaque: how far have we got?. Eur Heart J 2009, 30:2566-2574.
21. Tanaka S., Noda T., Segawa T., Iwama M., Minagawa T., Watanabe S., Minatoguchi S. Relation between functional stenosis and tissue characterization of intermediate coronary plaques in patients with stable coronary heart disease. J Cardiol 2010, 55:296-302.
22. Kodama K., Komatsu S., Ueda Y., Takayama T., Yajima J., Nanto S., Matsuoka H., Saito S., Hirayama A. Stabilization and regression of coronary plaques treated with pitavastatin proven by angioscopy and intravascular ultrasound-the TOGETHAR trial. Circ J 2010, 74:1922-1928.